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Development and validation of a simple spectrophotometric 
method for the determination of methyldopa in both bulk and 
marketed dosage formulations
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Centre for Social Science, Health and Technology, Federal University of Maranhão, Imperatriz, MA, Brazil
A simple, precise, sensitive, rapid, specific and economical spectrophotometric method was developed 
to determine methyldopa (MTD) content in bulk and pharmaceutical dosage formulations. The proposed 
method was based on the formation of a colored product from the nitrosation reaction of MTD with 
sodium nitrite in an acid medium. The resultant nitroso derivative species reacts further with sodium 
hydroxide and is converted it into a more stable compound. This yellow nitrosation product exhibited an 
absorption maximum at 430 nm. Beer’s Law was obeyed in a concentration range of 6.37 to 82.81 mg 
mL-1 MTD with an excellent coefficient of determination (R2 = 0.9998). No interference was observed 
from common excipients in formulations. The results showed the method to be simple, accurate and 
readily applied for the determination of MTD in pure form and in pharmaceutical preparations. The 
analytical results obtained for these products using the proposed method are in agreement with those of 
the Brazilian Pharmacopoeia procedure at a 95% confidence level.
Uniterms: Methyldopa/spectrophotometric determination. Pharmaceutical formulations/quality control. 
Spectrophotometry/qualitative analysis.
Desenvolveu-se método espectrofotométrico simples, preciso, sensível, rápido, específico e econômico 
para a determinação do teor de metildopa (MTD) em matéria-prima e em formulações farmacêuticas. O 
método proposto baseia-se na formação de um produto colorido resultante da reação de nitrosação da 
MTD com nitrito de sódio em meio ácido. A espécie resultante (nitroso derivado) reage com hidróxido 
de sódio e é convertida a um composto mais estável de cor amarela. Este produto exibiu máximo de 
absorção a 430 nm. A lei de Beer foi obedecida na faixa de concentração de 6,37 a 82,81 mg mL-1 de MTD 
com excelente coeficiente de determinação (R2 = 0,9998). Não se observou interferência de excipientes 
comumente encontrados em formulações farmacêuticas comerciais. Os resultados demonstraram que 
o método proposto apresenta simplicidade, excelentes precisão e exatidão e pode ser aplicado para a 
determinação de MTD na sua forma pura e em preparações farmacêuticas. Os resultados analíticos obtidos 
pelo método proposto estão de acordo com aqueles obtidos pelo método oficial descrito na Farmacopéia 
Brasileira, a um nível de confiança de 95%.
Unitermos: Metildopa/determinação espectrofotométrica. Formulações farmacêuticas/controle de 
qualidade. Espectrofotometria/análise qualitativa.
INTRODUCTION
Methyldopa (MTD), chemically known as 
a-methyl-3,4-dihydroxyphenylalanine (Figure 1), is a 
catechol derivative (catecholamine) widely used as an 
antihypertensive agent. MTD is a centrally acting alpha2-
adrenoreceptor agonist, which reduces sympathetic tone 
and produces a fall in blood pressure (Hoffman, 2005).
Several types of analytical procedures have been 
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FIGURE 1 - Chemical structure of methyldopa.
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employed for the analysis of catechol derivatives in 
pharmaceutical formulations and/or biological specimens. 
These procedures include: titrimetric determination 
(Walash, Abououf, Salem, 1982; Mohamed, Salem, 1984; 
Amin, 1986; Salem, 1987; Salem, 1993a; Farmacopeia 
Brasileira, 2010; USP, 2013), gas chromatography (Lee, 
Hong-You, Fowlie, 1989; Sharma et al., 1996), kinetic 
methods (Martinez-Lozano et al., 1991), fluorimetry 
(Salem, 1993b), chemiluminescence (Nozaki et al., 
1996; Nozaki et al., 1999), amperometry (Garrido, 
Lima, Delerue-Mattos, 1997), high-performance liquid 
chromatography (Tsuchiya et al., 1997; Parsons, Kerr, 
Weiss, 1998), voltammetric determination (Kozminski et 
al., 1998) and diffuse reflectance spectroscopy (Ribeiro, 
Pezza, Pezza, 2006). Some of these methods are complex 
for routine analysis and either require expensive or 
sophisticated instruments or involve procedures entailing 
rigorous control of the experimental conditions. Most of 
the titrimetric methods reported were indirect titrations and 
based on reduction reactions, which suffer interferences 
from unsaturated organic compounds. The official method 
reported in the Brazilian Pharmacopoeia (Farmacopeia 
brasileira, 2010) and in USP (2013) describes a nonaqueous 
titration for the assay of MTD.
Spectrophotometric methods have been proposed 
for the determination of catecholamines, such as 
MTD. A differential UV spectrophotometric procedure 
has also been used for the determination of MTD in 
pharmaceutical formulations in the presence of germanium 
dioxide at 292 nm (Davidson, 1984). MTD has been 
determined in the visible region after reaction with 
2,3,5-triphenyltetrazolium chloride (El-Rabbat, Omar, 
1978), potassium bromate (Mohamed, Salem, 1984), 
vanillin (Salem, 1985), p-dimethylaminocinnamaldehyde 
(Walash, Abououf, Salem, 1985), molybdophosphoric 
acid in sulphuric acid medium (Issopoulos, 1989), 
Fe(III), o-phenanthroline (Issopoulos, 1990), ferric 
chloride (Zivanovic, Vasiljevic, Radulovic, 1991), 
neotetrazolium chloride (Issopoulos, Economou, 
1993), metaperiodate (Nevado, Gallego, Laguna, 
1995), barbituric acid (Aman et al., 1998), isoniazid in 
the presence of N-bromosuccinimide (Nagaraja et al., 
1998), polyphenol oxidase enzyme (Vieira, Fatibello 
Filho, 1998), diazotized sulfanilamide in the presence 
of molybdate (Nagaraja, Vasantha, Sunitha, 2001a), 
semicarbazide hydrochloride in the presence of potassium 
persulfate (Nagaraja et al., 2001b), ammonium molybdate 
(Ribeiro et al., 2005a; Ribeiro, Pezza, Pezza, 2005b), 
2,2-diphenyl-picrylhydrazyl (Matos, Silva, Ribeiro, 2012) 
and ferric chloride/nitroso-R-salt (Al Abachi, Hadi, 2013). 
However, most of these methods suffer from several 
disadvantages, such as long-waiting times or a heating 
step for reaction development, instability of the colored 
species, complex procedure, requirement for nonaqueous 
media, poor detection limit, or lack of previous application 
to pharmaceutical formulations.
The present study reports a simple, precise, sensitive, 
rapid, specific and economical spectrophotometric method 
developed to determine the (MTD) content in bulk and 
pharmaceutical dosage formulations. The proposed 
method was based on the formation of a nitrous derivative 
of MTD. The yellow-colored product had maximum 
absorption at 430 nm. The proposed method has none of the 
disadvantages of interference from the excipients normally 
found with MTD in tablet dosage formulations and 
involves no extraction or heating steps. The method was 
used to determine MTD in pharmaceutical formulations. 
The results obtained by applying the proposed method 
showed relatively good agreement with those obtained 
using the standard procedure reported in the Brazilian 
Pharmacopoeia (Farmacapeia Brasileira, 2010) at a 95% 
confidence level.
MATERIAL AND METHODS
Apparatus
A Femto Model CIRRUS 80ST spectrophotometer 
with 1 cm matched silica cells was used for all absorbance 
measurements. Volume measurements were made 
with a plunger-operated pipetter (100-1000 mL) and 
Metrohm model 665 automatic burettes. All experiments 
were performed in a thermostatically-controlled room 
(25±1) °C. A Hanna Model Pack pH 21 digital pH-meter, 
calibrated with standard buffer solutions, was used for pH 
measurements.
Chemicals and reagents
All of the reagents used were of analytical reagent 
grade. Deionized water was used throughout the 
experiments.
A stock solution (MTDS – 318.4 mg ml-1) of MTD 
standard (Pharma Nostra – São Paulo, Brazil, purity grade 
> 99.2%) was prepared daily by dissolving 15.9 mg of the 
reference substance in water and diluting to the mark in a 
50 ml volumetric flask. Working standard solutions were 
obtained by appropriate dilution of this stock solution with 
the same solvent and were standardized using the standard 
procedure reported in the Brazilian Pharmacopoeia 
(Farmacopeia Brasileira, 2010).
Aqueous solutions of sodium nitrite [0.6 mol L-1] 
Development and validation of a simple spectrophotometric method for the determination of methyldopa 575
placing 2.25 to 0.50 mL of 1.5 × 10-3 mol L-1 sodium nitrite, 
and 1.0 mL of hydrochloric acid (1.6 x 10-2 mol L-1) into 
the flasks which were kept aside for 5 min; then 1.0 mL 
of sodium hydroxide (5.0 x 10-2 mol L-1) was added to the 
solution. After five minutes, the volume was then made 
up with deionized water. The absorbance was measured 
at 430 nm against the corresponding reagent blank. The 
results were plotted as shown in Figure 5, indicating the 
existence of 1:1 (MTD: sodium nitrite).
Stability study
The stability of the product formed under the above-
mentioned optimum conditions was investigated. For this 
study, a reference substance stock solution (50.94 mg mL-1 
of MTD) was transferred into a 5 mL calibrated flask and 
analyzed according to the recommended procedure for 
the calibration curve. This solution was kept for 24 h at 
room temperature and subsequently analyzed to test for 
short-term stability.
Intra-day precision (repeatability) and inter-day 
precision (intermediate precision) studies
MTD tablets were finely powdered and a sample 
stock solution (MTDP) of 318.4 mg mL-1 was prepared 
following the same dilution pattern of MTDS. Three 
different aliquots of MTDP were then diluted to obtain 
the concentrations of 31.84, 44.58 and 57.31 mg mL-1 and 
analyzed according to the recommended procedure for the 
calibration curve. The quantity per tablet was calculated 
from the standard calibration graph. This procedure was 
repeated on the two proceeding days.
Specificity in the presence of excipients
To assess the usefulness of the proposed method, the 
effect of the common components (additives, adjuvants 
and excipients) which often accompany MTD in tablet 
dosage formulations (silicon dioxide, sodium laureth 
sulfate, mannitol, sodium metabisulfite, polyethylene 
glycol, citric acid, lactose, microcrystalline cellulose, 
croscarmellose sodium, talc, starch and magnesium 
stearate) were investigated using the developed method. 
The ratios of the concentrations of MTD (44.58 mg mL-1) 
to the excipient substances were fixed at 1.0 and 10.0.
Procedure for the assay of MTD in pharmaceutical 
samples
Four market brands of MTD tablets purchased from 
local drugstores were randomly selected and analyzed 
using the newly developed and validated method. For 
the determination of MTD in pharmaceutical samples, 
the average tablet weight was calculated from the 
(Merck), sodium hydroxide [5.0 x 10-2 mol L-1] (Merck), 
and hydrochloric acid [1.6 x 10-2 mol L-1] (Merck) were 
prepared and used.
Pharmaceutical formulations (tablets) of four 
commercial brands were analyzed. These tablets were 
purchased from local drugstores and all were tested prior 
to their respective listed expiry dates. All pharmaceuticals 
studied were package labeled to contain 250 or 500 mg of 
MTD per tablet.
The excipients used in the interference study were of 
pharmaceutical grade. Thus, sucrose, glucose, talc, fructose, 
lactose, polyethylene glycol, microcrystalline cellulose, 
croscarmellose sodium, starch, polyvinylpyrrolidone 
and magnesium stearate were purchased from Sigma (St. 
Louis, MO, p. a.).
Methodology 
Determination of wavelength of maximum absorption
A reference substance stock solution (MTDS) 
(50.94 mg mL-1 of MTD) was transferred into a 5 mL 
calibrated flask. In this flask, 1.0 mL of hydrochloric 
acid (1.6 x 10-2 mol L-1) and 1.0 mL of sodium nitrite 
(0.6 mol L-1) were added and kept aside for 5 min; then 
1.0 mL of sodium hydroxide (5.0 x 10-2 mol L-1) was 
added to the solution. After five minutes, the volume 
was then made up with deionized water. A spectroscopic 
scan (400–800 nm) was carried out with this solution to 
determine the lmax for the detection of MTD, against the 
corresponding reagent blank.
Linearity and range
Aliquots of reference substance stock solution 
ranging from 6.37 to 82.81 mg mL-1 MTD were transferred 
to a series of 5.0 mL volumetric flasks. To each flask, 
1.0 mL of hydrochloric acid (1.6 x 10-2 mol L-1) and 
1.0 mL of sodium nitrite (0.6 mol L-1) were added and 
kept aside for 5 min; then 1.0 mL of sodium hydroxide 
(5.0 x 10-2 mol L-1) was added to the solution. After five 
minutes, the volume was then made up with deionized 
water. The absorbance was measured at 430 nm against 
the corresponding reagent blank. Calibration graphs 
were prepared by plotting absorbance against drug 
concentration. These graphs or the corresponding linear 
least squares equations were used to convert absorbance 
into MTD concentration, for any given analyzed sample.
Stoichiometric relationship
Job’s method (Foster, 1969) was applied by placing 
0.50 to 2.25 mL of 318.4 mg mL-1 MTD solution into a 
series of 10.0 mL volume flasks; this was followed by 
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contents of 20 tablets that were finely powdered and 
weighed. A portion of this powder, equivalent to ca. 
15.8 mg of MTD was accurately weighed and dissolved 
in 25 ml of deionized water by shaking for 15 min in a 
mechanical shaker. The resulting mixture was filtered 
and transferred into 50.0 mL graduated flasks, and the 
volume completed with deionized water. Aliquots from 
this solution, containing the equivalent of 44.58 mg mL-1 
of MTD, were transferred into 5.0 mL graduated flasks and 
analyzed according to the recommended procedure for the 
calibration curve. The quantity per tablet was calculated 
from the standard calibration graph.
Accuracy/recovery studies
To study the accuracy of the proposed method and 
determine the interference from the excipients used in the 
dosage forms, recovery experiments were carried out by 
the standard addition method. This study was performed 
by addition of known amounts (17.19; 19.10; 21.01 and 
22.92 mg mL-1, corresponding to levels of 90; 100; 110 
and 120%, respectively) of the standard substance (pure 
drug – MTD) to a known concentration of the previously 
analyzed commercial tablets (samples A, B, C and D). 
The resulting mixtures were analyzed according to 
the recommended procedure for the calibration curve. 
The recovery of drug was calculated by comparing the 
concentration obtained from the spiked mixtures with 
those of the pure drug.
RESULTS AND DISCUSSION
Sodium nitrite and hydrochloric acid react to 
produce nitrous acid (Figure 2, compound I). Owing to 
the presence of phenolic hydroxy groups in compounds 
(such as MTD – Figure 1), the reaction of this acid leads 
to the formation of nitroso derivatives (yellow-colored 
products – Figure 2, compound III) which are unstable 
(Suarez, Vieira, Fatibello Filho, 2005). The products 
formed in acid media are unstable but can be stabilized 
by the interaction with an alkaline reagent to form the 
highly stable compounds (Figure 2, compound IV). This 
indicates that the alkalinisation of the medium gives rise 
to the formation of a bathochromic shift, together with a 
hyperchromic effect (Belal et al., 1979).
The absorption spectrum of the colored product 
shows maximum absorption at 430 nm (Figure 3). Thus, 
the probable mechanism for the reaction between MTD 
(catecholamine) and the sodium nitrite in an acid medium 
involves the formation of nitroso derivatives as shown in 
Figure 2. This type of formation is probably due to the 
contribution of an extra pair of unshared electrons in the 
interaction with the aromatic nucleus (Daveu et al., 1997; 
d’Ischia, Costantini, 1995).
Method development and optimization
The effect of different volumes of the reagent 
used was investigated to obtain optimum results for the 
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FIGURE 2 - Suggested mechanism of nitration reaction of MTD.
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FIGURE 3 - Absorption spectrum of nitroso derivative of MTD 
in alkaline medium.
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determination of MTD. The optimum conditions were 
established based on the development of maximum 
color intensity and stability upon variation of parameters 
affecting the nitrosation reaction of MTD by the sodium 
nitrite in an acid medium.
Using different volumes of HCl and of NaOH, it 
was found that maximum color intensity and stability 
were obtained by developing the reactions in 1.0 mL 
of hydrochloric acid (1.6 × 10-2 mol L-1) and 1.0 mL of 
sodium hydroxide (5.0 × 10-2 mol L-1), as described in 
the recommended procedure. The adopted concentration 
of sodium nitrite (0.6 mol L-1) was found to be sufficient 
for providing maximum and repeatable color intensity, 
but when the concentration of reagent fell below this 
concentration the absorbance decreased while at higher 
concentrations the absorbance was not increased.
The order of addition of the reactants recommended 
in the general procedure produced quantitative results. 
Any other order was found to produce deviant results and 
reduced color intensity.
Linearity and range
The analytical curve (Figure 4) was obtained by the 
method of least squares from seven points, each of which 
was the average of three determinations. The proposed 
analytical method was validated by evaluating linear 
dynamic range, precision, limit of detection (LOD), and 
limit of quantitation (LOQ). Under the experimental 
described, Beer’s law was obeyed in the concentration 
range from 6.37 to 82.81 mg mL-1 MTD with an excellent 
coefficient of determination (R2 = 0.9998). The absorbance 
values for this concentration range were adjusted by the 
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FIGURE 4 - Analytical curve for determination of MTD.
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FIGURE 5 - Continuous variation plot for MTD with sodium 
nitrite.
equation: A=5.92×10-3+20.79×10-3 °C, where C is the 
concentration of MTD in mg mL-1 (molar absorptivity (ε): 
4.423 × 103 mol -1 cm -1). The LOD (3.SDblank/slope 
of curve) and LOQ (10.SDblank/slope of curve) were 
2.52 × 10-2 mg mL-1 and 7.68 × 10-2 mg mL-1 of MTD, 
respectively (ICH, 2005).
Determination of stoichiometric relationships
Job’s method of continuous variations (Foster, 1969) 
was employed for the determination of stoichiometric 
relationships: equimolar concentrations of MTD and 
sodium nitrite was found to be 1:1 (Figure 5).
Intra-day and inter-day precision
Assay precision was defined by determining intra-
day and inter-day precision, expressed as relative standard 
deviation (RSD). The inter-day variation was evaluated 
over 3 days. The intra-day and inter-day precision studies 
(Table I) of the developed method confirmed adequate 
sample stability and method reliability, where all the RSDs 
were < 2.0%.
Stability
The stability of the product formed under the above-
mentioned optimum conditions was investigated. The 
data given in Table II show that full color development 
is immediate at room temperature (25 °C) and the values 
of absorbance of the product formed were found to 
remain unchanged after standing for 24 hours at room 
temperature. This product was stable in the temperature 
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range of 20-60 oC. However, a temperature of 25 °C was 
chosen for the absorbance measurements.
Specificity in the presence of excipients
Since the aim of this study was to determine MTD 
in pharmaceuticals, the effects of the most commonly 
used excipients were carefully examined. The excipients 
studied were silicon dioxide, sodium laureth sulfate, 
mannitol, sodium metabisulfite, polyethylene glycol, citric 
acid, lactose, microcrystalline cellulose, croscarmellose 
sodium, talc, starch and magnesium stearate. For this study, 
solutions containing MTD and each of the excipients taken 
separately at concentrations greater than or equal to 10 
times that of MTD, were stirred with water in a magnetic 
mixer for 15 minutes, diluted, filtered when necessary, 
and analyzed under the same conditions described in the 
preparation of analytical curve.
The effect of each excipient was considered 
interference when the absorbance signal showed an error 
greater than or equal to 3.0% in the determination of the 
drug. The percentage of MTD found in these solutions 
ranged from 99.0 to 100.5%, with coefficient of variation 
values of less than 2.0% for three replicates, indicating 
that no interferences were observed under the studied 
conditions.
Content of MTD in marketed brands
The samples were prepared using the developed 
method. The proposed method was successfully applied 
for the determination of MTD in four tablet formulations. 
The results given in Table III compared favorably with 
the official method (Farmacopeia Brasileira, 2010), at 
95% confidence level, confirming the applicability of 
the proposed method for the determination of MTD in 
pharmaceutical dosage forms (tablets).
The results were subjected to a paired comparison 
test (Miller, Miller, 1993); the data of t and F ratios show 
no significant differences between the results of the 
proposed and the official methods, at a 95% confidence 
level. The RSD values obtained for the samples ranged 
from 0.7 to 3.8%, as shown in Table III. According to 
Horwitz (1982), the maximum RSD value acceptable 
for the working level of the analyte (48.58 μg mL-1) is 
8.0%. The AOAC (1993) set the maximum acceptable 
RSD value at 5.3% for the same analyte level. Therefore, 
the spectrophotometric method for determination of 
MTD in pharmaceutical formulations reported in this 
paper is precise, accurate, and suitable for use in routine 
analysis.
Accuracy/recovery and repeatability studies
In order to investigate the presence of matrix effects 
and to check the accuracy and precision of the developed 
method a recovery study was also carried out. The results 
of the recovery tests are given in Table IV. The mean 
recovery values for all samples within the 100.0–101.0% 
range and RSD within 0.9–1.6% confirm an accurate and 
precise method for application to pharmaceutical dosage 
TABLE I - Intra-day and inter-day precision determined for three different concentrations of MTD (n = 3)
Concentration 
(µg mL-1)
Intra-day precision Inter-day precision
Absorbance 
measured 
(Mean ± SD)
RSD 
(%)
Average potency 
(%)
Absorbance 
measured 
(Mean ± SD)
RSD 
(%)
Average potency 
(%)
31.84 0.6636 ± 0.0015 0.2260 99.77 0.6720 ± 0.0038 0.5655 101.04
44.58 0.9239 ± 0.0033 0.3572 98.92 0.9261 ± 0.0054 0.5831 99.15
57.31 1.2084 ± 0.0099 0.8293 100.81 1.2101 ± 0.0087 0.7189 100.95
TABLE II - Optical stability of the reaction product at room 
temperature (25 °C)a
Time (min) Absorbance b
0 1.0630
5 1.0624
10 1.0622
15 1.0622
20 1.0635
25 1.0643
30 1.0633
35 c 1.0619
aMTD concentration: 50.94 mg mL-1. bMeasurements taken 
at 430 nm against the reagent blank for reactants at room 
temperature (25 °C), as described in the recommended 
procedure. cAbsorbance remains unchanged after standing for 
24 hours at 25 °C.
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TABLE III - Determination of MTD in commercial pharmaceutical preparations
Sample Label valuea 
Proposed method Official method
Found b RSD (%) c t-value (2.78)d F-value (19.00) d Foundb RSD (%)c
A 250.0 274.2 ± 10.4 3.8 1.87 3.00 261.2 ± 6.0 2.3
B 250.0 255.6 ± 5.2 2.0 1.33 1.13 250.1 ± 4.9 2.0
C 500.0 501.0 ± 4.5 0.9 2.65 2.99 493.0 ± 2.6 0.5
D 500.0 499.7 ± 3.5 0.7 2.41 3.78 505.2 ± 1.8 1.4
aLabel for content in tablets: mg unit –1. bAverage value ± standard deviation (SD) of three determinations. cRelative standard 
deviation (RSD) of three determinations. dFigures between parentheses are the theoretical values of t and F at P = 0.05.
TABLE IV - Recovery/accuracy data of the proposed method for the pharmaceutical formulations spiked with four different 
concentrations of MTD
Sample Added (µg mL-1) Found (µg mL-1) Recovery (%)a
A 17.19 
19.10 
21.01 
22.92
17.51 
19.04 
21.20 
23.22
101.9 
99.7 
100.9 
101.3 
m a = 101.0 ± 0.9
B 17.19 
19.10 
21.01 
22.92
17.10 
19.46 
21.18 
22.85
99.5 
101.9 
100.8 
99.7 
m a = 100.5 ± 1.1
C 17.19 
19.10 
21.01 
22.92
17.53 
19.27 
21.37 
22.76
102.0 
100.9 
101.7 
99.3 
m a = 100.9 ± 1.2
D 17.19 
19.10 
21.01 
22.92
17.07 
19.33 
20.61 
23.26
99.3 
101.2 
98.1 
101.5 
m a = 100.0 ± 1.6
a Average ± relative standard deviation (RSD) of three determinations.
forms. Thus, the results indicate no interference from any 
of the excipients present in tablets.
In the repeatability study, the RSD was 2.0; 1.1; 
1.4 and 0.9% for solution (samples A, B, C and D, 
respectively) containing an equivalent of 44.58 mg mL-1 
of MTD (n = 10). These results reveal good precision of 
the proposed method.
CONCLUSION
The proposed method represents a very simple, 
cheap, rapid, precise, accurate, highly sensitive and 
environmentally-friendly (low consumption of reagents/
solvents) analytical method for determining MTD in 
commercial pharmaceutical preparations with satisfactory 
recovery. Additionally, the approach fulfils all the main 
requirements of routine analysis as it is robust, has a low 
instrumentation and operational cost in comparison to 
chromatographic methods, and involves no pre-treatment 
of the sample.
When applied to the assay of various tablet dosage 
forms, it offers the advantage of not requiring removal 
of usual excipients since these did not interfere with the 
determination of MTD. Therefore, the method can be 
useful in routine quality control analysis of MTD.
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